Nonalcoholic steatohepatitis (NASH) research at Mayo Clinic May 05, 2021 Overview Show transcript Overview Harmeet Malhi, M.B.B.S., discusses current research efforts focusing on how and why the liver becomes injured in NASH. Dr. Malhi is Gastroenterology and Hepatology associate chair for research at Mayo Clinic in Rochester, Minnesota. Share Doximity Facebook LinkedIn Twitter Print details Receive Mayo Clinic news in your inbox. Sign up Related ContentArticleUse of weight-loss pharmacotherapy in patients with cirrhosis and in liver transplant recipientsArticleTransforming noninvasive liver disease detection by MRE: the hepatogramArticleNAFLD and NASH research update VID-20515071 Medical Professionals Nonalcoholic steatohepatitis (NASH) research at Mayo Clinic